Lilly rises on vaccine deals
Eli Lilly plans nearly $4 billion in vaccine deals to expand infectious disease research. The move aims to boost the company's presence in the sector.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.